Correlation Between Rea and PYC Therapeutics

Can any of the company-specific risk be diversified away by investing in both Rea and PYC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rea and PYC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rea Group and PYC Therapeutics, you can compare the effects of market volatilities on Rea and PYC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rea with a short position of PYC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rea and PYC Therapeutics.

Diversification Opportunities for Rea and PYC Therapeutics

-0.02

Correlation Coefficient

Rea  PYC Therapeutics

Good diversification

The 3 months correlation between Rea and PYC is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Rea Group and PYC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PYC Therapeutics and Rea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rea Group are associated (or correlated) with PYC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PYC Therapeutics has no effect on the direction of Rea i.e., Rea and PYC Therapeutics go up and down completely randomly.

Pair Corralation between Rea and PYC Therapeutics

Assuming the 90 days trading horizon Rea Group is expected to generate 0.35 times more return on investment than PYC Therapeutics. However, Rea Group is 2.86 times less risky than PYC Therapeutics. It trades about -0.21 of its potential returns per unit of risk. PYC Therapeutics is currently generating about -0.29 per unit of risk. If you would invest  25,103  in Rea Group on September 27, 2024 and sell it today you would lose (1,687) from holding Rea Group or give up 6.72% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Rea Group  vs.  PYC Therapeutics

Rea Group

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Rea Group are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Rea unveiled solid returns over the last few months and may actually be approaching a breakup point.

PYC Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PYC Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Rea and PYC Therapeutics

The main advantage of trading using opposite Rea and PYC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rea position performs unexpectedly, PYC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PYC Therapeutics will offset losses from the drop in PYC Therapeutics' long position.

The idea behind Rea Group and PYC Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.